BioLattice

Revolutionizing Cornea Repair

Philadelphia, United States · Founded 2014 · $2.1M raised

Employees
1–10
Founded
2014
Business Model
B2B
Total Funding
$2.1M
Last Round
$1.8M Pre-SeedOct 2024
Rounds
2

About

BioLattice Ophthalmics is an award-winning tissue engineering company founded by Amelia Zellander, PhD (tissue engineer and pharmaceutical scientist) and Linda Alunkal, MBA. The company is developing CorneaClear, a synthetic corneal implant designed as a true alternative to donor corneas. With 2 million people suffering from corneal blindness annually and only 1 in 70 patients obtaining donor tissue, BioLattice's engineered cornea also offers corrective vision capabilities. The company has received funding from Life Sciences Greenhouse Investments (LSGI) and won multiple pitch competitions including HiveBio's Silicon Valley competition ($20K) and the Startup of the Year award. Based in Philadelphia and backed by federal grants before transitioning to VC funding.

Summary

BioLattice is a Biotech company based in Philadelphia, United States, founded in 2014. It has raised $2.1M in total across 2 rounds, most recently a $1.8M Pre-Seed round in Oct 2024.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Pre-seedPre-SeedOct 2024
$1.8M

Sign up to see all 2 rounds

Grant through Pre-Seed — per-round amounts, valuations, and who invested in each round.

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BioLattice on Indexed.vc
<a href="https://indexed.vc/companies/biolattice"><img src="https://indexed.vc/api/badge/company/biolattice" alt="BioLattice on Indexed.vc" width="260" height="76" /></a>